GeneOne Life Science (XKRX:011000) Ending Cash Position : ₩1,180 Mil (As of Dec. 2024)

View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Ending Cash Position?

GeneOne Life Science's Ending Cash Position for the quarter that ended in Dec. 2024 was ₩1,180 Mil.

GeneOne Life Science's quarterly Ending Cash Position declined from Jun. 2024 (₩2,064 Mil) to Sep. 2024 (₩840 Mil) but then increased from Sep. 2024 (₩840 Mil) to Dec. 2024 (₩1,180 Mil).

GeneOne Life Science's annual Ending Cash Position declined from Dec. 2022 (₩13,261 Mil) to Dec. 2023 (₩9,111 Mil) and declined from Dec. 2023 (₩9,111 Mil) to Dec. 2024 (₩1,180 Mil).

GeneOne Life Science Ending Cash Position Historical Data

The historical data trend for GeneOne Life Science's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Ending Cash Position Chart

GeneOne Life Science Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

62,432.01

22,309.65

13,260.90

9,110.82

1,180.18

GeneOne Life Science Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															9,110.82	7,700.19	2,063.72	839.59	1,180.18

GeneOne Life Science Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GeneOne Life Science's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9110.821	+	-7930.645
	=	1,180

GeneOne Life Science's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	839.593	+	340.583
	=	1,180

GeneOne Life Science Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GeneOne Life Science's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneOne Life Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

343, Hakdong-ro, Gangnam-Gu, Seoul, KOR

Website

http://www.genels.com

GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science Headlines

No Headlines